[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [marketticker...] --------------------------------------------------------------- Sponsor Message [Biden's "Death Knell for the Dollar"]( President Biden’s Executive Order 14067 could lead to a shocking new reality that would “fundamentally change the structure of America’s entire financial system...” Wall Street legend Ian King has just released [his newest presentation detailing the latest plot against you and your money ... and what you can do about it.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- November 24, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Copper More Critical than Lithium?]( [be7e813c-17c...](Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Puma Biotechnology, PBYI]( Recent Analyst Action: Edward White, analyst at H.C. Wainwright, reiterates coverage on [Puma Biotechnology (PBYI)](in the Healthcare sector with a Buy rating and a price target of $8.00 (2 weeks ago). - Recent Price: $4.73 - Average Analyst Price Target: $8.00 (69.13%) - Market Cap: $215.88M [TipRanks.com]( also reports that [Puma Biotechnology](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $8.00. [Puma Biotechnology (PBYI)](’s last closing price was $4.73 which would put the average price target at $8.00. Here are 3rd party ratings for [PBYI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 22% (55 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Millionaire Investor Reveals: "How I Made My Second Fortune... By Avoiding 99% of Stocks"]( [eb528704-62b...](Buy this small group of unique stocks… never sell them… and make all the money you need… No matter what happens in the market. [Revealed here: the name and ticker of the #1 stock.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Clearfield, CLFD]( Recent Analyst Action: Tim Savageaux, analyst at Northland Securities, reiterates coverage on [Clearfield (CLFD)](in the Technology sector with a Buy rating and a price target of $120.00 (6 days ago). - Recent Price: $129.5 - Average Analyst Price Target: $130.00 (0.39%) - Market Cap: $1.78B [TipRanks.com]( also reports that [Clearfield](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $130.00. The target pricing ranges from a high forecast of $135.00 down to a low forecast of $120.00. [Clearfield (CLFD)](’s last closing price was $129.5 which would put the average price target at $130.00. Here are 3rd party ratings for [CLFD](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Bottom 41% (148 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Polestar Automotive Holding UK, PSNY]( Recent Analyst Action: Itay Michaeli, analyst at Citigroup, reiterates coverage on [Polestar Automotive Holding UK (PSNY)](in the Consumer Goods sector with a Buy rating and a price target of $12.00 (1 week ago). - Recent Price: $7.87 - Average Analyst Price Target: $10.50 (33.42%) - Market Cap: $3.68B [TipRanks.com]( also reports that [Polestar Automotive Holding UK](currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $10.50. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $9.00. [Polestar Automotive Holding UK (PSNY)](’s last closing price was $7.87 which would put the average price target at $10.50. Here are 3rd party ratings for [PSNY](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [American Eagle, AEO]( Recent Analyst Action: Paul Lejuez, analyst at Citigroup, reiterates coverage on [American Eagle (AEO)](in the Consumer Goods sector with a Hold rating and a price target of $17.00 (1 day ago). - Recent Price: $15.8 - Average Analyst Price Target: $14.90 (-5.70%) - Market Cap: $2.96B [TipRanks.com]( also reports that [American Eagle](currently has 10 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $14.90. The target pricing ranges from a high forecast of $17.00 down to a low forecast of $12.00. [American Eagle (AEO)](’s last closing price was $15.8 which would put the average price target at $14.90. Here are 3rd party ratings for [AEO](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 44% (140 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Ikena Oncology, IKNA]( Recent Analyst Action: Robert Burns, analyst at H.C. Wainwright, reiterates coverage on [Ikena Oncology (IKNA)](in the Healthcare sector with a Buy rating and a price target of $26.00 (6 days ago). - Recent Price: $2.56 - Average Analyst Price Target: $22.00 (759.38%) - Market Cap: $92.82M [TipRanks.com]( also reports that [Ikena Oncology](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $22.00. The target pricing ranges from a high forecast of $26.00 down to a low forecast of $18.00. [Ikena Oncology (IKNA)](’s last closing price was $2.56 which would put the average price target at $22.00. Here are 3rd party ratings for [IKNA](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 22% (55 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [US Dollar Replaced By "Biden Bucks"?]( [17ceb2c1-94c...](A former advisor to the CIA and Pentagon now believes President Biden plans to retire the US dollar we know. And replace it with what he calls “Biden Bucks”. It is underway. On March 9, Biden signed Executive Order 14067, which could pave the way for Biden Bucks. [Click to see how to save your investment and retirement accounts.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [BioVie, BIVI]( Recent Analyst Action: Constantine Davides, analyst at EF Hutton, reiterates coverage on [BioVie (BIVI)](in the Healthcare sector with a Buy rating and a price target of $8.00 (1 month ago). - Recent Price: $6.12 - Average Analyst Price Target: $10.00 (63.40%) - Market Cap: $186.86M [TipRanks.com]( also reports that [BioVie](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $8.00. [BioVie (BIVI)](’s last closing price was $6.12 which would put the average price target at $10.00. Here are 3rd party ratings for [BIVI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 32% (81 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Allego, ALLG]( Recent Analyst Action: Matt Summerville, analyst at D.A. Davidson, reiterates coverage on [Allego (ALLG)](in the Consumer Goods sector with a Buy rating and a price target of $10.00 (1 week ago). - Recent Price: $4.08 - Average Analyst Price Target: $8.00 (96.08%) - Market Cap: $1.09B [TipRanks.com]( also reports that [Allego](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $4.00. [Allego (ALLG)](’s last closing price was $4.08 which would put the average price target at $8.00. Here are 3rd party ratings for [ALLG](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Hold, Bottom 42% (145 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [These 2 Dividend Stocks Pay Every Week]( [bc82e8e3-d6f...](Are you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software